Description
At Bayer, we're launching a dynamic Institutional & Specialty Sales team to bring Asundexian, a next-generation stroke prevention therapy, to market. As a Pharmaceutical Sales Representative, you will have a rare opportunity to shape access, accelerate clinical adoption, and play a pivotal role in a high-profile neurology launch,delivering innovation to patients when it matters most.
This role will cover the geography of Las Vegas, NV - South and candidates must be domiciled within the territory. You will drive clinical demand, education, and sales by communicating the value of Asundexian in stroke prevention. You will lead formulary access by navigating P&T committees and influencing protocol adoption across health systems. You will build strategic relationships with priority institutions, including key stakeholders at the institutions (i.e., C and D Suite and Head of Pharmacy, Head of Quality), and neurologists.
As an Institutional & Specialty Pharmaceutical Sales Consultant, you will develop territory business plans based on local market insights and collaborate with internal teams to support a successful launch. You will demonstrate expertise and knowledge of disease state, the marketplace, competitors, industry, and cross-functional activities/plans, as well as possessing the analytical rigor to anticipate and identify business opportunities and challenges. You will analyze competitive landscape and proactively identify opportunities and risks.
This is an extraordinary opportunity to be part of a new team launching Asundexian, an oral Factor XIa inhibitor. You will have access to top-tier compensation, healthcare coverage, and financial security programs,including a 401(k) with up to 10% company contributions, Employee Stock Purchase Plan, and Retiree Medical Account. You will receive exceptional family support, including paid parental leave, fertility benefits, and adoption support. You will also have employee discount on all Bayer Consumer Health products and robust Performance-driven quarterly incentive.